CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 14 of 23

RMD Open

Briefs 521–560 of 899 CurrentRheuma has covered from this journal, newest publication first

Latest from RMD Open

All coverage, newest first

  1. RMD Open

    Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis

    Cohort studySpondyloarthritis & PsA

  2. RMD Open

    International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe

    Cross-sectional studySpondyloarthritis & PsA

  3. RMD Open

    Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies

    Secondary analysisSpondyloarthritis & PsA

  4. RMD Open

    PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

    Randomized controlled trialRA

  5. RMD Open

    Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study

    Randomized controlled trialRA

  6. RMD Open

    Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren’s syndrome

    Cohort studySjögren's & overlap

  7. RMD Open

    Dysregulation of circulating collagen turnover markers in very early systemic sclerosis

    Cross-sectional studySystemic sclerosis

  8. RMD Open

    Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort

    Cohort studySpondyloarthritis & PsA

  9. RMD Open

    Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects

    Secondary analysis

  10. RMD Open

    Natural language processing to identify and characterize spondyloarthritis in clinical practice

    Cohort studySpondyloarthritis & PsA

  11. RMD Open

    Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid

    Cohort studyFibromyalgia & pain

  12. RMD Open

    Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies

    Cohort studyAcross diseases

  13. RMD Open

    Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort

    Cohort studySystemic sclerosis

  14. RMD Open

    Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence

    Cross-sectional studyRA

  15. RMD Open

    Exploring complement biomarkers in suspected axial spondyloarthritis

    Cross-sectional studySpondyloarthritis & PsA

  16. RMD Open

    Cryoneurolysis versus radiofrequency ablation outcome on pain experience in chronic low back pain (COPE): a single-blinded randomised controlled trial

    Randomized controlled trialFibromyalgia & pain

  17. RMD Open

    Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status

    Secondary analysisSpondyloarthritis & PsA

  18. RMD Open

    MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value

    Diagnostic or prognostic studyVasculitis & PMR

  19. RMD Open

    Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study

    Secondary analysisRA

  20. RMD Open

    Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis

    Diagnostic or prognostic studyVasculitis & PMR

  21. RMD Open

    Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study

    Cohort studyVasculitis & PMR

  22. RMD Open

    Spatiotemporal changes in imaging features associated with diffuse idiopathic skeletal hyperostosis (DISH)

    Cohort study

  23. RMD Open

    Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort

    Cohort studySjögren's & overlap

  24. RMD Open

    Development and validation of a self-updating gout register from electronic health records data

    Diagnostic or prognostic studyGout & crystals

  25. RMD Open

    Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study

    Cohort studyAcross diseases

  26. RMD Open

    Optimising gout treatment: insights from a nurse-led cohort study

    Cohort studyGout & crystals

  27. RMD Open

    Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease

    Diagnostic or prognostic studyMyositis

  28. RMD Open

    Primary Sjögren’s syndrome independently promotes premature subclinical atherosclerosis

    Cross-sectional studySjögren's & overlap

  29. RMD Open

    Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology

    Cohort studyAcross diseases

  30. RMD Open

    Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort

    Case-control studyLupus & APS

  31. RMD Open

    Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    Cohort studySpondyloarthritis & PsA

  32. RMD Open

    Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study

    Research articleRA

  33. RMD Open

    Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

    Cohort studyRA

  34. RMD Open

    Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

    Secondary analysisRA

  35. RMD Open

    Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?

    Cohort studyLupus & APS

  36. RMD Open

    Associations between life course longitudinal growth and hip shapes at ages 60–64 years: evidence from the MRC National Survey of Health and Development

    Cohort studyOsteoarthritis

  37. RMD Open

    Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren’s syndrome and Sicca

    Cross-sectional studySjögren's & overlap

  38. RMD Open

    Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2

    Meta-analysisSpondyloarthritis & PsA

  39. RMD Open

    Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden

    Cohort studyVasculitis & PMR

  40. RMD Open

    Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test

    Cohort studyRA

All 899 Briefs in ExploreShowing Briefs 521–560 of 899, newest first